期刊文献+

胶质母细胞瘤手术治疗预后因素分析 被引量:4

下载PDF
导出
摘要 目的:探讨影响胶质母细胞瘤术后生存的相关因素。方法:总结42例胶质母细胞瘤患者术后经化疗及伽玛刀治疗的生存期,采用Kaplan-Meier绘制生存曲线,用Log-rank检验和Cox多因素回归分析进行治疗预后相关因素分析。结果:经Log-rank检验术后行伽玛刀治疗有较长的生存期,其中经术前健康状况自我评分标准(KPS),证实KPS>80分以上及继发性患者的生存期比较长。Cox多因素回归分析显示肿瘤性质是影响生存期的预后相关因素(P<0.05)。结论:胶质母细胞瘤的预后与术前KPS评分、肿瘤性质有密切相关,治疗方式从生存曲线显示联合放疗和联合伽玛刀治疗有较长的生存期。
出处 《实用医学杂志》 CAS 北大核心 2012年第6期945-948,共4页 The Journal of Practical Medicine
  • 相关文献

参考文献18

  • 1王世勇,柯以铨.血管生成拟态在胶质母细胞瘤中的研究进展[J].中华神经医学杂志,2011,10(8):859-861. 被引量:7
  • 2王忠诚.神经外科学[M].武汉:湖北科学技术出版社,2010:18.
  • 3Macdonald Dr.Temozolomide for recurrent high-grade gliomas[J].Semin Oncol,2001,28(4 Suppl 13):3-12.
  • 4Kleinberg L,Grossman S A.The effects of sequential versus concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high grade astrocytoma[J].Inter J Radiat Oncol Biol Phys,1999,44(3):535-543.
  • 5Coffey R J.Boost gamma knife radiosurgery in the treatment of primary glialtumors[J].Stereotact Funct Neurosurg,1993,61 (suppl 1):59-64.
  • 6Gilbert H,Kagan A R,Cassidy F,et al.Glioblastoma multiforme is not a uniform disease[J].Cancer Clin Tri,1981,4(1):87-89.
  • 7Cohadon F.Indications for surgery in the management of gliomas[J].Adv Tech Stand Neurosurg,1990,17:189-234.
  • 8徐庆中.胶质母细胞瘤的病理组织学及分子遗传学与患者预后的关系[J].中国神经肿瘤杂志,2009,7(2):148-152. 被引量:5
  • 9Burger P C,Green S B.Patientage,histological,and length of survivalin patient with glioblastoma multiforme[J].Cancer,1987,59(9):1617-1625.
  • 10刘秀芳,夏云飞,柳青,韩非.164例胶质瘤术后放射治疗疗效及预后[J].中华放射肿瘤学杂志,2001,10(2):108-111. 被引量:54

二级参考文献17

  • 1席桂发,陈坚,董震,王代旭,柯超.p53和p16蛋白在星形细胞瘤中的表达及其意义[J].肿瘤防治研究,2004,31(8):474-476. 被引量:2
  • 2Yao KC, Komata T, Kondo Y, et al. Molecular response of human glioblastoma multiforme cells to ionizing radiation: cell cycle arrest, modulation of the expression of cyclin-dependent kinase inhibitors, and autophagy[J]. J Neurosurg, 2003, 98(2): 378-384.
  • 3Gross MW, Kraus A, Nashwan K, et al. Expression of p53 and p21 in primary glioblastomas[J]. Strahlenthcr Onkol, 2005, 181 (3):164-171.
  • 4Hayashi Y, Yamashita J, Watanabe T. Molecular genetic analysis of deep-seated glioblastomas[J]. Cancer Genet Cytogenet, 2004, 153(1): 64-68.
  • 5Amalfitano G, Chatel M, Paquis P, et al. Fluorescence in situ hybridization study of aneuploidy of chromosomes 7, 10, X, and Y in primary and secondary glioblastomas [J]. Cancer Genet Cytogenet, 2000, 116(1): 6-9.
  • 6Ohgaki H. Genetic pathways to glioblastomas[J]. Neuropathology,2005, 25(1): 1-7.
  • 7Das A, Tan WL, Teo J, et al. Glioblastoma multiforme in an Asian population: evidence for a distinct genetic pathway [J]. J Neurooncol, 2002, 60(2): 117-125.
  • 8Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: a population-based study[J]. Cancer Res, 2004, 64(19): 6892-6899.
  • 9Rich JN, Hans C, Jones B, et al. Gene expression profiling and genetic markers in glioblastoma survival[J]. Cancer Res, 2005, 65(10): 4051-4058.
  • 10Batchelor TT, Betensky RA, Esposito JM, et al. Age-dependent prognostic effects of genetic alterations in glioblastoma [J]. Clin Cancer Res, 2004, 10(1): 228-233.

共引文献79

同被引文献27

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部